• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $OSTX

    OS Therapies Incorporated

    Subscribe to $OSTX
    $OSTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    IPO Year: 2024

    Exchange: AMEX

    Recent Analyst Ratings for OS Therapies Incorporated

    DatePrice TargetRatingAnalyst
    4/2/2025$19.00Buy
    Lake Street
    See more ratings

    OS Therapies Incorporated Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Former 10% Owner Auerbach Shalom

      4 - OS Therapies Inc (0001795091) (Issuer)

      5/9/25 9:45:04 PM ET
      $OSTX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Large owner Auerbach Shalom sold $163,918 worth of shares (82,000 units at $2.00) (SEC Form 4)

      4 - OS Therapies Inc (0001795091) (Issuer)

      5/9/25 9:30:13 PM ET
      $OSTX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Large owner Auerbach Shalom sold $81,566 worth of shares (60,012 units at $1.36) (SEC Form 4)

      4 - OS Therapies Inc (0001795091) (Issuer)

      4/11/25 9:45:07 PM ET
      $OSTX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • President and CEO Romness Paul A. acquired 225,000 shares, increasing direct ownership by 10% to 2,473,000 units (SEC Form 4)

      4 - OS Therapies Inc (0001795091) (Issuer)

      2/28/25 6:03:39 PM ET
      $OSTX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Large owner Auerbach Shalom disposed of $369,000 worth of shares (225,000 units at $1.64) (SEC Form 4)

      4 - OS Therapies Inc (0001795091) (Issuer)

      2/28/25 4:05:20 PM ET
      $OSTX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: New insider Auerbach Shalom claimed ownership of 1,404,375 shares (SEC Form 3)

      3/A - OS Therapies Inc (0001795091) (Issuer)

      2/26/25 4:30:34 PM ET
      $OSTX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Large owner Auerbach Shalom sold $284,300 worth of shares (100,000 units at $2.84) (SEC Form 4)

      4 - OS Therapies Inc (0001795091) (Issuer)

      2/18/25 9:00:01 PM ET
      $OSTX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 5 filed by Search Theodore F.

      5 - OS Therapies Inc (0001795091) (Issuer)

      2/14/25 4:26:15 PM ET
      $OSTX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 5 filed by Romness Paul A.

      5 - OS Therapies Inc (0001795091) (Issuer)

      2/14/25 4:25:31 PM ET
      $OSTX
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 5 filed by Mckean-Dieser Avril Suzette

      5 - OS Therapies Inc (0001795091) (Issuer)

      2/14/25 4:24:49 PM ET
      $OSTX
      Biotechnology: Pharmaceutical Preparations
      Health Care